Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)

Henry Ford Health System

Overview

The purpose of this study is to validate a new hand held light emitting diode (LED) device for the measurement of minimal erythema dose (MED) for narrow band Ultraviolet B (UVB) radiation by comparing to the traditional approach of measurement of the minimal erythema dose.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

OTHER

Masking

NONE

Conditions

Phototherapy

Interventions

LED phototherapyOTHER

narrowband UVB phototherapyOTHER

Eligibility

Sex: ALLMin age: 18 YearsMax age: 120 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1\. Age greater than 18 years. Exclusion Criteria: 1. Pregnancy 2. Lactation 3. History of photosensitivity disorder 4. Photosensitizing medications 5. Personal history of melanoma or non-melanoma skin cancer. 6. Skin disease on the back

Locations (1)

Henry Ford Medical Center Department of Dermatology

Detroit, Michigan, United States

Outcomes

Primary Outcomes

Minimal Erythema Dose

The Investigator will look at area irradiated and evaluate for erythema. The lowest dose at which erythema is noted will be recorded as the minimal erythema dose.

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.